相关实验视频
Updated: Jan 14, 2026

05:10
Multidisciplinary Approach to Obesity Management: A Case Report
Published on: May 30, 2025
902
抗糖尿病药物和肥胖管理的艺术和科学
Shalini K Sawhney1, Anandi Kapri2, Gaurav Chaudhary1
1ITS College of Pharmacy, Muradnagar, Ghaziabad, Uttar Pradesh, India.
Mini reviews in medicinal chemistry
|October 20, 2025
概括
本综述探讨了糖尿病药物如何影响血红蛋白A1c (HbA1c) 和体重. 一些药物有助于减肥和改善血糖控制,而其他药物则是体重中立或导致体重增加.
科学领域:
- 内分泌学 在内分泌学.
- 药理学 药理学是指药理学的学科.
- 代谢疾病 代谢疾病
背景情况:
- 血糖控制对于管理1型和2型糖尿病以及预防并发症至关重要.
- 抗糖尿病药物对体重和血糖控制 (HbA1c) 的影响有所不同.
- 饮食和运动等生活方式因素显著影响药物的有效性和体重控制.
研究的目的:
- 根据它们对体重和HbA1c水平的影响对抗糖尿病药物进行分类.
- 审查已批准用于糖尿病患者减肥管理的药物.
- 探索某些药物影响体重和心血管风险的机制.
主要方法:
- 关于抗糖尿病药物的文献综述.
- 对血红蛋白A1c (HbA1c) 和体重药物影响的分析.
- 检查已批准用于糖尿病体重管理的药物.
主要成果:
- 一些抗糖尿病药物通过增加葡萄糖分泌或减少肝脏葡萄糖生产来促进体重减轻.
- 某些药物是体重中立的,对大多数患者的体重影响最小.
- 一些药物提供体重减轻的好处,以及额外的血糖效应,可能减少心血管死亡率和发病率.
结论:
- 药物选择,以及生活方式,决定了糖尿病管理中的体重和血糖指数.
- 需要进一步的研究来阐明某些抗糖尿病药物延长生命的机制.
- 草药和抗糖尿病药物之间的潜在相互作用需要仔细考虑.
相关概念视频
Diabetes: Management and Pharmacotherapy
861
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
861
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
245
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
245
Carbohydrate Metabolism
13.8K
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
13.8K
Drug Dosing: Obese Patients
218
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
218
Diabetes Mellitus: Type 2 and Gestational
4.3K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.3K
Oral Hypoglycemic Agents: Biguanides and Glitazones
582
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
582

